Related Experiment Video

Updated: Dec 13, 2025

Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

696

EN2 as an oncogene promotes tumor progression via regulating CCL20 in colorectal cancer

Yimin Li1, Jiaxin Liu1, Qing Xiao1

  • 1Department of Pathology, Xiangya Hospital, School of Basic Medical Sciences, Central South University, Changsha, China.

Cell Death & Disease
|August 1, 2020
PubMed

Insights

Engrailed-2 (EN2) acts as an oncogene in colorectal cancer (CRC), promoting tumor progression. Targeting EN2 and its downstream target, Chemokine ligand 20 (CCL20), may offer new therapeutic strategies for CRC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Engrailed-2 (EN2) is implicated in various cancers, but its role in colorectal cancer (CRC) remains unclear.
  • Understanding EN2's function in CRC is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the expression and clinical significance of EN2 in colorectal cancer.
  • To elucidate the underlying mechanisms of EN2's role in CRC progression.

Main Methods:

  • Quantitative analysis of EN2 expression in CRC tissues versus normal tissues.
  • In vitro cell proliferation and migration assays following EN2 knockdown.
  • In vivo tumorigenicity studies.
  • Identification and validation of EN2's direct target genes using molecular techniques.

Main Results:

  • EN2 was significantly upregulated in CRC tissues and associated with poorer patient survival.
  • EN2 knockdown inhibited CRC cell proliferation, migration, and in vivo tumor growth.
  • Chemokine ligand 20 (CCL20) was identified as a direct downstream target of EN2.
  • EN2 promoted CRC cell proliferation and migration by regulating CCL20 expression.

Conclusions:

  • EN2 functions as an oncogene in colorectal cancer progression.
  • EN2 and its target CCL20 represent potential therapeutic targets for CRC treatment and prevention.

More Related Videos

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

14.2K
Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.8K

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.5K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.7K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.2K